Halozyme (HALO) Faces Patent Challenge as USPTO Institutes Revie – GuruFocus
Halozyme (HALO) Faces Patent Challenge as USPTO Institutes Revie GuruFocus
In: PATENT NEWS
Halozyme (HALO) Faces Patent Challenge as USPTO Institutes Revie GuruFocus
In: PATENT NEWS
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform GlobeNewswire
In: PATENT NEWS
Halozyme (HALO) Faces Patent Challenges Affecting Stock Outlook | HALO Stock News GuruFocus
In: PATENT NEWS
Major AI Patent Breakthrough: Renovaro’s New Technology Could Transform Drug Discovery Process Stock Titan
In: PATENT NEWS
PTAB Finds Return Mail Inapplicable to Alleged Chinese Control Over TikTok in Motion to Terminate IPRs IPWatchdog.com
In: PATENT NEWS
HeartSciences Inc. Secures Foundational Patent for AI-Driven ECG Technology Enhancing Heart Function Detection Nasdaq
In: PATENT NEWS
Roadzen Inc. Secures Patent for DrivebuddyAI’s Real-Time Driver Drowsiness Detection Algorithm in India Nasdaq
In: PATENT NEWS
Trethera Secures New License, Strengthening TRE-515 GlobeNewswire
In: PATENT NEWS
Roadzen’s DrivebuddyAI Awarded Patent for Real-Time Driver GlobeNewswire
In: PATENT NEWS
Foreign Patent Trolls Wreak Havoc at the U.S. International Trade Commission RealClearPolicy
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION